Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Sydnexis
Sydnexis
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Sydnexis
Sydnexis Summary
Company Summary
Overview
Sydnexis is a clinical-stage biopharmaceutical company developing a proprietary formulation for decreasing myopic progression in children. It offers SYD-101, an eyedrop formulation.
Type
Private
Status
Active
Founded
2014
HQ
Del Mar, CA, US
|
view all locations
Website
http://www.sydnexis.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
kids
pharma
Homepage
Table of Contents
Key People
Locations
Competitors
Key People
Ken Widder,
Chief Executive Officer and Director
Jacki Johnson,
Chief Operating Officer
Patrick Johnson,
Chief Business Officer
Locations
View all
1 location detected
Del Mar, CA
HQ
United States
445 Marine View Ave #295
Competitors and Similar Companies
Afecta Pharmaceuticals
Healthcare - Private
Orphan Star Therapeutics
Healthcare - Private
Infant Bacterial Therapeutics
Healthcare - Public
Genentech
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top